retatrutide clinical trials retatrutide mechanism Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide—A Game Changer in Obesity

SURMOUNT-MAINTAIN randomized patients who had lost weight on the maximum dose of tirzepatide to either continue at full dose of 10 or 15 mg, reduce to 5 mg, or switch to placebo for an additional year

UK Regulatory Status and Expected Timeline The UK pathway for a medicine like retatrutide involves more than scientific enthusiasm

Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X, Ouyang C, Liu X, Liu C, Chen Q (2023) Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats

doi: 10.1002/jnr.22565 167 McGovernSFHunterKHolscherC

Moreover, unhealthy weight can take a toll on your mental and emotional health